Effects of acute nicotine administration on behavioral inhibition in adolescents with attention-deficit/hyperactivity disorder

Psychopharmacology

Volumn 176, Issue 2, 2004, Pages 183-194

  Potter, Alexandra S ^a   Newhouse, Paul A ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

ADHD; Adolescents; Behavioral inhibition; Nicotine; Smoking; Stop signal task

Indexed keywords

METHYLPHENIDATE; NICOTINE; PLACEBO;

ACCURACY; ADOLESCENT; ARTICLE; ATTENTION DEFICIT DISORDER; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; LEARNING; MALE; NAUSEA; PRIORITY JOURNAL; PSYCHOLOGIC TEST; REACTION TIME; SMOKING; STATISTICAL SIGNIFICANCE; TASK PERFORMANCE; VOMITING;

EID: 8744228882     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-004-1874-y     Document Type: Article

References (82)

1. Abreu-Villaca Y, Seidler FJ, Tate CA, Slotkin TA (2003) Nicotine is a neurotoxin in the adolescent brain: critical periods, patterns of exposure, regional selectivity, and dose thresholds for macromolecular alterations. Brain Res 979:114-128
2. Adams EH, Korberly BH, Maquire MK, Franzon MA (2001) Post-market surveillance of Nicotrol products - the nicotine patch, inhaler, and nasal spray. 3rd SRNT Europe Conference 3
3. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders. US Government Printing Office, Washington D.C.
4. Barkley RA (1997a) Attention-deficit/hyperactivity disorder, self-regulation, and time: toward a more comprehensive theory. J Dev Behav Pediatr 18:271-279
5. Barkley RA (1997b) Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD. Psychol Bull 121:65-94
6. Barkley RA, Fischer M, Edelbrock CS, Smallish L (1990a) The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 29:546-557
7. Barkley RA, McMurray MB, Edelbrock CS, Robbins K (1990b) Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation. Pediatrics 86:184-92
8. Barkley RA, Anastopoulos AD, Guevremont DC, Fletcher KE (1991) Adolescents with ADHD: patterns of behavioral adjustment, academic functioning, and treatment utilization. J Am Acad Child Adolesc Psychiatry 30:752-61
9. Biederman J, Faraone SV, Milberger S, Guite J, Mick E (1996) A prospective 4-year follow-up study of attention-deficit/hyperactivity and related disorders. Arch Gen Psychiatry 53:437-446
10. Burke JD, Loeber R, Lahey BB (2001) Which aspects of ADHD are associated with tobacco use in early adolescence? J Child Psychol Psychiatry 42:493-502
11. Bush G, Frazier J, Rauch S, Seidman L, Whalen P, Jenike M et al. (1999) Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the counting stroop. Biol Psychiatry 45:1542-1552
12. Centers for Disease Control and Prevention (1995) Tobacco use and usual source of cigarettes among high school students. Morb Mortal Weeldy Rep 45:413-418
13. Clarke PBS, Hommer DW, Pert A, Skirboll LR (1985) Electrophysiological actions of nicotine on substantia nigra single units. Br J Pharmacol 85:827-835
14. Cohen JD, Servan-Schreiber D (1992) A neural network model of disturbances in the processing of context in schizophrenia. Psychiatr Ann 22:131-136
15. Costello EJ, Armstrong TD, Erkanli A (2000) Report on the developmental epidemiology of comorbid psychiatric and substance use disorders. Presented to the National Institute on Drug Abuse. Duke University Medical Center, Durham, N.C.
16. Denney CB, Rapport MD (2001) Cognitive pharmacology of stimulants in children with ADHD. In: Solanto MV, Arnsten AF, Castellanos FX (eds) Stimulant drugs and ADHD. Oxford University Press, Oxford, pp 282-302
17. Disney ER, Elkins IJ, McGue M, Iacono W (1999) Effects of ADHD, conduct disorder, and gender on substance use and abuse in adolescents. Am J Psychiatry 156:1515-1521
18. Douglas VI (1983) Attention and cognitive problems. In: Rutter M (ed) Developmental neuropsychiatry. Guilford Press, New York, pp 280-329
19. Fertig JB, Pomerleau O, Sanders B (1986) Nicotine-produced aninociception in minimally deprived smokers and ex-smokers. Addict Behav 11:239-248
20. 3H]dopamine release from synaptosomes prepared from mouse striatum. J Neurochem 59:848-856
21. Hughes JR, Strickler G, King D, Higgins ST, Fenwick JW, Gulliver SB et al. (1989a) Smoking history, instructions and the effects of nicotine: two pilot studies. Pharmacol Biochem Behav 34:149-155
22. Hughes JR, Strickler G, King D, Higgins ST, Fenwick JW, Gulliver SB et al. (1989b) Smoking history, instructions and the effects of nicotine: two pilot studies. Pharmacol Biochem Behav 34:149-155
23. Jennings JR, Van der molen MW, Pelham W, Brock K, Hoza B (1997) Inhibition in boys with attention deficit hyperactivity disorder as indexed by heart rate change. Dev Psychol 33:308-318
24. van Kammen DP, Murphy DL (1975) Attenuation of the euphoria and activating effects of D-amphetamine and L-amphetamine by lithium carbonate treatment. Psychopharmacology 44:215-224
25. Kramer AF, Cepeda NJ, Cepeda ML (2001) Methylphenadate effects on task-switching performance in attention-deficit/ hyperactivity disorder. J Am Acad Child Adolesc 40:1277-1284
26. Krause K, Dresel SH, Krause J, la Fougere C, Ackenheil M (2003) The dopamine transporter and neuroimaging in attention deficit hyperactivity disorder. Neurosci Biobehav Rev 27:605-613
27. Lambert NM, Hartsough CS (1998) Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants. J Learn Disabil 31:533-44
28. Levin ED, Lee C, Rose JE, Reyes A, Ellison G, Jarvik M et al (1990) Chronic nicotine and withdrawal effects on radial-arm maze performance in rats. Behav Neural Biol 53:269-276
29. Levin ED, Conners CK, Sparrow E, Hinton S, Meek W, Rose JE et al. (1996) Nicotine effects on adults with attention-deficit/ hyperactivity disorder. Psychopharmacology 123:55-63
30. Levin ED, Wilson W, Rose J, McEvoy J (1996) Nicotine-haloperidol interactions and cognitive performance in schizophrenics. Neuropsychopharmacology 15:429-436
31. Levin ED, Conners CK, Silva D, Hinton SC, Meek WH, March J et al. (1998) Transdermal nicotine effects on attention. Psychopharmacology 140:135-141
32. 2 hippocampal nicotinic receptor blockade and systemic nicotine effects on memory function in rats. Soc Neurosci 78.3
33. Levin ED, Conners CK, Silva D, Canu W, March J (2001) Effects of chronic nicotine and methylphenidate in adults with ADHD. Exp Clin Psychopharmacol 9:83-90
34. 2 nicotinic receptors and working memory. Neuroscience 109:757-765
35. Logan GD, Cowan WB, Davis KA (1984) On the ability to inhibit simple and choice reaction time responses: a model and a method. J Exp Psychol [Hum Percep Perform] 10:276-291
36. Lufi D, Cohen A, Parish-Plass J (1990) Identifying attention deficit hyperactive disorder with the WISC-R and the Stroop color and word test. Psychol Schools, pp 28-34
37. MacLeod D, Prior M (1996) Attention deficits in adolescents with ADHD and other clinical groups. Child Neuropsychol 2:1-10
38. Mancuso G, Warburton DM, Melen M, Sherwood N, Tirelli E (1999) Selective effects of nicotine on attentional processes. Psychopharmacology 146:199-204
39. Marshall DL, Redfern PH, Wonnacott S (1997) Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: comparison of naive and chronic nicotine-treated rats. J Neurochem 68:1511-1519
40. McNair DM, Lorr M, Droppleman LF (1971) Profile of mood states. Educational and Industrial Testing Service, San Diego, Calif.
41. Meru G, Yoon KP, Boi V, Gessa GL, Naes L, Westfall TC (1987) Preferential stimulation of ventral tegmental area dopaminergic neurons by nicotine. Eur J Pharmacol 141:395-399
42. Milberger S, Beiderman J, Faraone SV, Chen L, Jones J (1997) ADHD is associated with early initiation of cigarette smoking in children and adolescents. J Am Acad Child Adolesc Psychiatry 36:37-44
43. Molina BSG, Pelham WE Jr (2003) Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD. J Abnorm Psychol 112:497-507
44. Newhouse PA, Potter A, Corwin J, Lenox R (1992) Acute nicotinic blockade produces cognitive impairment in normal humans. Psychopharmacology 108:480-484
45. Newhouse P, Potter A, Corwin J (1996a) Acute administration of the cholinergic channel activator ABT-418 improves learning in Alzheimer's disease. Soc Res Nicotine Tobacco: Poster A39
46. Newhouse P, Potter A, Corwin J (1996b) Effects of nicotinic cholinergic agents on cognitive functioning in Alzheimer's and Parkinson's disease. Drug Dev Res 38:278-289
47. Nigg JT (2000) On inhibition/disinhibition in developmental psychopathology: views from cognitive and personality psychology and a working inhibition taxonomy. Psychol Bull 126:220-246
48. Nigg JT (2001) Is ADHD a disinhibitory disorder? Psychol Bull 127:571-98
49. Oosterlaan J, Logan GD, Sergeant JA (1998) Response inhibition in AD/HD, CD, comorbid AD/HD and CD, anxious and control children: a meta-analysis of studies with the stop task. J Child Psychol Psychiatr 39:411-26
50. Overtoom CCE, Kenemans JL, Verbaten MN, Kemner C, van der Molen MW, van Engeland H et al. (2002) Inhibition in children with attention-deficit/ hyperactivity disorder: a psychophysiological study of the stop task. Biol Psychiatry 51:668-676
51. Parrott AC, Craig D (1992) Cigarette smoking and nicotine gum (0, 2, and 4 mg) effects upon four visual attention tasks. Neuropsychobiology 25:34-43
52. Pennington BF, Ozonoff S (1996) Executive functions and developmental psychopathology. J Child Psychol Psychiatry 37:51-87
53. Pliszka SR, Borcherding SH, Spratley K, Leon, S (1997) Measuring inhibitory control in children. J Dev Behav Pediatr 18:254-259
54. Pomerleau OF, Downey KK, Stelson FW, Pomerleau CS (1995) Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder. J Subst Abuse 7:373-378
55. Potter A, Corwin J, Lang J, Piasecki M, Lenox R, Newhouse P (1999) Acute effects of the selective cholinergic channel activator (nicotinic agonist) ABT-418 in Alzheimer's disease. Psychopharmacology 142:334-342
56. Provost SC, Woodward R (1991) Effects of nicotine gum on repeated administration of the Stroop test. Psychopharmacology 104:536-540
57. Quay HC (1997) Inhibition and attention deficit hyperactivity disorder. J Abnorm Child Psychol 25:7-13
58. Rapier C, Lunt GG, Wonnacott S (1988) Stereoselective nicotine-induced release of dopamine from striatal synaptosomes: concentration dependence and repetitive stimulation. J Neurochem 50:1123-1130
59. 3H]dopamine release from striatal synaptosomes: pharmacological characterisation. J Neurochem 54:937-45
60. Rapport MD, Kelly KL (1993) Psychostimulant effects on learning and cognitive performance. Handbook of hyperactivity in children. Allyn & Bacon, Boston, Mass., pp 97-136
61. Rhodes J, Green J, Thomas G (1998) Nicotine and the Gastrointestinal Tract. In: Benowitz NL (ed) Nicotine safety and toxicity. Oxford University Press, Oxford, pp 161-166
62. Rubia K, Overmeyer S, Taylor E (1999) Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: a study with functional MRI. Am J Psychiatry 156:891-896
63. Sahakian BJ, Jones GMM (1991) The effects of nicotine on attention, information processing, and working memory in patients with dementia of the Alzheimer type. In: Adlkofer F, Thruau K (eds) Effects of nicotine on biological systems. Birkhauser Verlag, Basel, pp 623-230
64. Schachar R, Logan GD (1990) Impulsivity and inhibitory control in normal development and childhood psychopathology. Dev Psychol 26:710-720
65. Schachar R, Tannock R, Marriott M, Logan G (1995) Deficient inhibitory control in attention deficit hyperactivity disorder. J Abnorm Child Psychol 23:411-37
66. Shytle RD, Silver AA, Philipp MK, McConville BJ, Sanberg PR (1996) Transdermal nicotine for Tourette's syndrome. Drug Dev Res 38:290-298
67. Shytle DR, Silver AA, Wilkinson BJ, Sanberg PR (2002) A pilot controlled trial of transdermal nicotine in the treatment of attention deficit hyperactivity disorder. World J Biol Psychiatry 3:150-155
68. Snodgrass J, Corwin J (1988) Pragmatics of measuring recognition memory: applications to dementia and amnesia. J Exp Psychol 117:34-50
69. Solanto MV (2002) Dopamine dysfunction in AD/HD: integrating clinical and basic neuroscience. Behav Brain Res 130:65-71
70. Spear LP (2000) The adolescent brain and age-related behavioral manifestations. Neurosci Biobehav Rev 24:417-463
71. Tannock R, Schachar RJ, Logan GD (1995) Methylphenidate and cognitive flexibility: dissociated dose effects in hyperactive children. J Abnorm Child Psychol 23:253-266
72. Taylor FB, Russo J (2001) Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol 21:223-228
73. Tidey JW, O'Neill SC, Higgins ST (2000) D-amphetamine increases choice of cigarette smoking over monetary reinforcement. Psychopharmacology 153:85-92
74. Vaidya CJ, Austin G, Kirkorian G (1998) Selective effects of methylphenidate in attention deficit hyperactivity disorder: a functional magnetic resonance study. Proc Natl Acad Sci 94:14494-14495
75. van Boxtel GJM, van der Molen MW, Jennings JR, Brunia CHM (2001) A psychophysiological analysis of inhibitory motor control in the stop-signal paradigm. Biol Psychol 58:229-262
76. Wesnes K, Warburton DM (1983) Smoking, nicotine and human performance. Pharmacol Ther 21:189-208
77. White HK, Levin ED (1999) Chronic four week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease. Psychopharmacology 143:158-165
78. White HK, Levin ED (2004) Chronic transdermal nicotine patch treatment effects on cognitive performance in age-associated memory impairment. Psychopharmacology 171:465-471
79. Whiteaker P, Garcha HS, Wonnacott S, Stolerman IP (1995) Locomotor activation and dopamine release produced by nicotine and isoarecolone in rats. Br J Pharmacol 116:2097-2105
80. Wilens TE, Biederman J, Spencer TJ, Bostic J, Prince J, Monuteaux MC et al. (1999) A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder. Am J Psychiatry 156:1931-1937
81. Wilkison PC, Kircher JC, McMahon WM, Sloane HN (1995) Effects of methylphenidate on reward strength in boys with attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 34:897-901
82. Williams BR, Ponesse JS, Schachar RJ, Logan GD, Tannock R (1999) Development of inhibitory control across the life span. Dev Psychol 35:205-213